NASDAQ:AGLE
Aeglea BioTherapeutics, Inc.
- Stock
Last Close
11.26
27/11 21:00
Market Cap
48.63M
Beta: 1.76
Volume Today
43.24K
Avg: 725.60K
PE Ratio
−0.18
PFCF: −0.56
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | -407.50K - | -407.50K 0% | |||||||||
average payables | 268K - | 247.50K 7.65% | 172K 30.51% | 278.50K 61.92% | 526K 88.87% | 1.91M 262.83% | 2.70M 41.68% | 2.79M 3.05% | 2.00M 28.30% | 786.50K 60.64% | |
average receivables | 848.50K - | 1.46M 71.60% | 2.15M 47.42% | 1.54M 28.30% | 407.50K - | 595K 46.01% | 187.50K 68.49% | ||||
book value per share | 0.27 - | 3.16 1,050.79% | 6.43 103.58% | 3.33 48.26% | 3.24 2.68% | 1.88 41.93% | 2.62 39.32% | 1.28 51.27% | 0.60 53.25% | 25.07 4,100.09% | |
capex per share | -0.03 - | -0.02 31.43% | -0.02 18.97% | -0.04 88.98% | -0.02 50.47% | -0.05 130.42% | -0.08 71.72% | -0.01 89.13% | -0.00 94.83% | ||
capex to depreciation | -9.53 - | -2.34 75.47% | -1.61 31.28% | -2.49 54.79% | -1.44 42.06% | -3.57 147.83% | -4.30 20.39% | -0.36 91.54% | -0.02 93.33% | ||
capex to operating cash flow | 0.02 - | 0.02 23.25% | 0.01 40.59% | 0.03 123.48% | 0.01 47.87% | 0.02 73.26% | 0.06 148.69% | 0.01 81.11% | 0.00 95.56% | ||
capex to revenue | -0.03 - | -0.05 34.01% | -0.12 159.61% | -0.11 8.73% | -0.03 - | -0.02 46.64% | |||||
cash per share | 0.38 - | 2.89 654.12% | 6.49 124.20% | 3.32 48.73% | 3.58 7.63% | 2.25 37.07% | 2.74 21.70% | 1.42 48.31% | 0.66 53.33% | 46.22 6,892.42% | |
days of inventory on hand | |||||||||||
days payables outstanding | 339.25 - | ||||||||||
days sales outstanding | 101.79 - | 95.82 5.86% | 215.84 125.25% | 15.87 - | 58.77 270.21% | ||||||
debt to assets | 0.05 - | 0.09 72.98% | 0.06 - | 0.03 44.62% | 0.05 36.12% | 0.07 41.80% | 0.25 280.14% | ||||
debt to equity | 0.06 - | 0.10 80.93% | 0.08 - | 0.04 53.77% | 0.06 54.23% | 0.09 53.14% | 0.46 399.35% | ||||
dividend yield | |||||||||||
earnings yield | -0.01 - | -0.00 34.86% | -0.02 403.64% | -0.01 34.67% | -0.01 14.55% | -0.01 9.05% | -0.01 38.35% | -0.01 10.22% | -0.09 948.82% | -2.14 2,326.24% | |
enterprise value | 1.66B - | 2.76B 66.09% | 1.02B 63.18% | 2.03B 99.91% | 3.88B 90.66% | 6.09B 57.05% | 10.42B 71.09% | 7.80B 25.15% | 917.92M 88.23% | 53.63M 94.16% | |
enterprise value over ebitda | -223.52 - | -246.08 10.09% | -47.16 80.83% | -75.34 59.75% | -87.99 16.79% | -75.79 13.87% | -129.42 70.77% | -118.77 8.23% | -10.83 90.88% | -0.42 96.13% | |
ev to operating cash flow | -226.75 - | -251.54 10.94% | -53.99 78.54% | -82.60 53.01% | -120.42 45.78% | -92.68 23.04% | -137.46 48.32% | -145.15 5.59% | -11.45 92.11% | -0.54 95.31% | |
ev to sales | 453.98 - | 219.77 51.59% | 390.64 77.75% | 997.06 155.24% | 416.09 - | 394.13 5.28% | 60.53 84.64% | ||||
free cash flow per share | -1.10 - | -0.98 11.16% | -1.95 98.74% | -1.67 14.27% | -1.57 6.10% | -2.10 34.25% | -1.50 28.67% | -0.83 44.95% | -0.95 15.21% | -13.61 1,330.69% | |
free cash flow yield | -0.00 - | -0.00 11.16% | -0.02 346.37% | -0.01 31.07% | -0.01 32.17% | -0.01 31.61% | -0.01 30.75% | -0.01 8.79% | -0.08 1,116.12% | -0.63 647.92% | |
graham net net | 0.23 - | 2.78 1,117.30% | 6.16 121.51% | 3.10 49.71% | 3.08 0.48% | 1.53 50.41% | 2.33 52.56% | 1.02 56.08% | 0.42 59.28% | 24.72 5,826.08% | |
graham number | 3.06 - | 8.38 173.78% | 17.91 113.66% | 11.61 35.16% | 12.46 7.30% | 10.01 19.63% | 9.42 5.94% | 5.36 43.06% | 3.65 31.85% | ||
income quality | 0.71 - | 0.97 37.15% | 0.87 10.70% | 0.90 4.09% | 0.73 19.68% | 0.84 15.64% | 0.94 11.59% | 0.82 12.85% | 0.96 17.13% | 0.29 69.16% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -101.29 - | ||||||||||
interest debt per share | 0.36 - | 0.33 6.38% | 0.16 - | 0.10 35.59% | 0.08 24.84% | 0.06 15.47% | 11.52 17,661.68% | ||||
inventory turnover | |||||||||||
invested capital | 0.06 - | 0.10 80.93% | 0.08 - | 0.04 53.77% | 0.06 54.23% | 0.09 53.14% | 309.55M 336,399,065,572.93% | ||||
market cap | 1.67B - | 2.79B 67.59% | 1.06B 61.86% | 2.05B 92.15% | 3.90B 90.56% | 6.10B 56.51% | 10.50B 72.08% | 7.81B 25.65% | 948.16M 87.86% | 157.96M 83.34% | |
net current asset value | 1.67M - | 35.74M 2,037.32% | 62.33M 74.41% | 49.25M 20.98% | 66.36M 34.74% | 51.40M 22.54% | 128.00M 149.02% | 72.91M 43.04% | 41.42M 43.19% | 183.69M 343.48% | |
net debt to ebitda | 0.35 - | 2.61 642.24% | 2.21 15.15% | 0.47 78.55% | 0.51 7.35% | 0.18 65.35% | 1.05 495.41% | 0.15 85.37% | 0.36 131.84% | 0.82 128.90% | |
net income per share | -1.52 - | -0.99 34.86% | -2.22 124.24% | -1.80 18.76% | -2.13 18.30% | -2.37 11.24% | -1.50 36.49% | -1.00 33.48% | -0.99 0.64% | -46.15 4,541.12% | |
operating cash flow per share | -1.08 - | -0.96 10.66% | -1.92 100.25% | -1.63 15.43% | -1.55 4.98% | -2.06 32.99% | -1.42 30.95% | -0.82 42.45% | -0.95 16.39% | -13.61 1,331.37% | |
payables turnover | 1.08 - | ||||||||||
receivables turnover | 3.59 - | 3.81 6.23% | 1.69 55.60% | 22.99 - | 6.21 72.99% | ||||||
research and ddevelopement to revenue | 1.88 - | 3.92 108.28% | 4.38 11.81% | 9.44 115.46% | 3.05 - | 25.15 725.88% | 101.02 301.64% | ||||
return on tangible assets | -3.53 - | -0.29 91.73% | -0.32 10.72% | -0.49 50.11% | -0.57 17.46% | -0.91 59.51% | -0.50 45.40% | -0.60 20.48% | -1.18 96.81% | -0.99 15.88% | |
revenue per share | 0.53 - | 0.47 11.22% | 0.34 27.21% | 0.19 45.73% | 0.29 - | 0.03 90.30% | 0.12 336.80% | ||||
roe | -5.53 - | -0.31 94.34% | -0.34 10.15% | -0.54 57.02% | -0.66 21.56% | -1.26 91.55% | -0.57 54.42% | -0.78 36.51% | -1.67 112.55% | -1.84 10.50% | |
roic | -5.42 - | -0.31 94.23% | -0.33 5.20% | -0.50 51.60% | -0.67 35.00% | -1.11 64.36% | -0.54 51.52% | -0.70 30.39% | -1.42 103.10% | -0.78 44.98% | |
sales general and administrative to revenue | 0.98 - | 1.81 85.52% | 1.93 6.66% | 3.25 68.00% | 1.46 - | 12.25 740.29% | 45.09 268.04% | ||||
shareholders equity per share | 0.27 - | 3.16 1,050.79% | 6.43 103.58% | 3.33 48.26% | 3.24 2.68% | 1.88 41.93% | 2.62 39.32% | 1.28 51.27% | 0.60 53.25% | 25.07 4,100.09% | |
stock based compensation to revenue | 0.13 - | 0.26 109.31% | 0.48 81.47% | 1.10 129.93% | 0.43 - | 3.05 611.80% | 28.98 849.11% | ||||
tangible asset value | 1.87M - | 36.10M 1,828.63% | 62.97M 74.40% | 50.34M 20.06% | 67.43M 33.95% | 60.08M 10.90% | 139.83M 132.74% | 83.94M 39.97% | 50.30M 40.07% | 184.02M 265.80% | |
tangible book value per share | 0.27 - | 3.16 1,050.79% | 6.43 103.58% | 3.33 48.26% | 3.24 2.68% | 1.88 41.93% | 2.62 39.32% | 1.28 51.27% | 0.60 53.25% | 25.07 4,100.09% | |
working capital | 1.67M - | 35.76M 2,038.94% | 62.46M 74.65% | 49.36M 20.97% | 66.43M 34.58% | 56.15M 15.48% | 133.35M 137.50% | 78.75M 40.95% | 47.60M 39.55% | 309.55M 550.29% |
All numbers in USD (except ratios and percentages)